EP0599417A3 - Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay. - Google Patents

Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay. Download PDF

Info

Publication number
EP0599417A3
EP0599417A3 EP93203247A EP93203247A EP0599417A3 EP 0599417 A3 EP0599417 A3 EP 0599417A3 EP 93203247 A EP93203247 A EP 93203247A EP 93203247 A EP93203247 A EP 93203247A EP 0599417 A3 EP0599417 A3 EP 0599417A3
Authority
EP
European Patent Office
Prior art keywords
immunoassay
reagent
immunocomplex
dissociate
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP93203247A
Other languages
English (en)
French (fr)
Other versions
EP0599417B1 (de
EP0599417A2 (de
Inventor
Jones Marvin Hyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25528576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0599417(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of EP0599417A2 publication Critical patent/EP0599417A2/de
Publication of EP0599417A3 publication Critical patent/EP0599417A3/de
Application granted granted Critical
Publication of EP0599417B1 publication Critical patent/EP0599417B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Selective Calling Equipment (AREA)
  • Seasonings (AREA)
  • Gyroscopes (AREA)
EP93203247A 1992-11-25 1993-11-19 Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay Expired - Lifetime EP0599417B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/981,689 US5384240A (en) 1992-11-25 1992-11-25 Base dissociation assay
US981689 1992-11-25

Publications (3)

Publication Number Publication Date
EP0599417A2 EP0599417A2 (de) 1994-06-01
EP0599417A3 true EP0599417A3 (de) 1995-05-17
EP0599417B1 EP0599417B1 (de) 2002-08-28

Family

ID=25528576

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93203247A Expired - Lifetime EP0599417B1 (de) 1992-11-25 1993-11-19 Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay

Country Status (13)

Country Link
US (1) US5384240A (de)
EP (1) EP0599417B1 (de)
JP (1) JP3398199B2 (de)
KR (1) KR100326619B1 (de)
AT (1) ATE223050T1 (de)
AU (1) AU674353B2 (de)
CA (1) CA2109855A1 (de)
DE (1) DE69332236T2 (de)
DK (1) DK0599417T3 (de)
ES (1) ES2182825T3 (de)
FI (1) FI935217A (de)
PT (1) PT599417E (de)
ZA (1) ZA938726B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
DE59712575D1 (de) * 1996-12-19 2006-04-20 Dade Behring Marburg Gmbh Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
CN1207569C (zh) * 1997-08-04 2005-06-22 株式会社先端生命科学研究所 用于测定含病毒样品的方法、病毒测定方法和诊断试剂盒
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
US20090118421A1 (en) * 2007-11-02 2009-05-07 Momentive Performance Materials Inc. Copolymer of epoxy compounds and amino silanes
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20100297610A1 (en) * 2009-04-15 2010-11-25 Columbia Biosystems Molecularly imprinted polymers for detecting hiv-1
EP2365332B1 (de) * 2010-03-10 2013-05-29 Institut Pasteur HMGB1- und anti-HMGB1-Antikörper bei HIV-infizierten Patienten, insbesondere mit neurologischen Störungen
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
JP5630866B2 (ja) * 2010-12-24 2014-11-26 栄研化学株式会社 Ｈｉｖの検出方法
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN104697830B (zh) * 2015-02-10 2018-06-15 深圳市新产业生物医学工程股份有限公司 用于hiv检测的酸性处理剂、样本预处理方法、试剂盒及检测方法
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3465217A1 (de) * 2016-05-31 2019-04-10 Roche Diagnostics GmbH Verfahren zum serologischen nachweis von virusantigenen
KR20190076897A (ko) * 2017-12-22 2019-07-02 주식회사 수젠텍 결핵 진단 방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299812A (en) * 1978-11-29 1981-11-10 Diagnostic Products Corp. Immunoassay of thyroxine in neonates using dried blood samples
EP0080109A1 (de) * 1981-11-19 1983-06-01 New York Blood Center, Inc. Empfindliche Immunotests von in Immunenkomplexen sequestrierten Antigenen oder Antikörpern
EP0363110A2 (de) * 1988-10-07 1990-04-11 Johnson & Johnson Clinical Diagnostics, Inc. Hoch-pH-Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Antigenen aus Chlamydia, Gonokokken oder Herpes
EP0382519A2 (de) * 1989-02-09 1990-08-16 Eastman Kodak Company Extraktionszusammensetzung, Testsatz und deren Verwendung zum Nachweis von Herpes-Simplex-Antigen
WO1990009594A2 (en) * 1989-02-09 1990-08-23 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965191A (en) * 1988-02-12 1990-10-23 Eastman Kodak Company Lower alcohol sulfate wash solution, test kit and method for the determination of an immunological ligand
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
US5047325A (en) * 1988-10-07 1991-09-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5210039A (en) * 1989-02-09 1993-05-11 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299812A (en) * 1978-11-29 1981-11-10 Diagnostic Products Corp. Immunoassay of thyroxine in neonates using dried blood samples
EP0080109A1 (de) * 1981-11-19 1983-06-01 New York Blood Center, Inc. Empfindliche Immunotests von in Immunenkomplexen sequestrierten Antigenen oder Antikörpern
EP0363110A2 (de) * 1988-10-07 1990-04-11 Johnson & Johnson Clinical Diagnostics, Inc. Hoch-pH-Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Antigenen aus Chlamydia, Gonokokken oder Herpes
EP0382519A2 (de) * 1989-02-09 1990-08-16 Eastman Kodak Company Extraktionszusammensetzung, Testsatz und deren Verwendung zum Nachweis von Herpes-Simplex-Antigen
WO1990009594A2 (en) * 1989-02-09 1990-08-23 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NISHANIAN ET AL.: "A simple method for improved assay ....", THE JOURNAL OF INFECTIOUS DISEASES, vol. 162, no. 1, July 1990 (1990-07-01), CHICAGO, ILL., pages 21 - 28, XP009039537 *

Also Published As

Publication number Publication date
ES2182825T3 (es) 2003-03-16
FI935217A0 (fi) 1993-11-24
EP0599417B1 (de) 2002-08-28
JP3398199B2 (ja) 2003-04-21
KR940011950A (ko) 1994-06-22
US5384240A (en) 1995-01-24
AU5190793A (en) 1994-06-09
AU674353B2 (en) 1996-12-19
PT599417E (pt) 2002-12-31
CA2109855A1 (en) 1994-05-26
DK0599417T3 (da) 2003-01-06
JPH06242112A (ja) 1994-09-02
KR100326619B1 (ko) 2002-06-20
DE69332236T2 (de) 2003-04-17
EP0599417A2 (de) 1994-06-01
DE69332236D1 (de) 2002-10-02
ATE223050T1 (de) 2002-09-15
ZA938726B (en) 1994-08-01
FI935217A (fi) 1994-05-26

Similar Documents

Publication Publication Date Title
EP0599417A3 (de) Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay.
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
CY1108299T1 (el) Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου
ATE233814T1 (de) Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
JPS6457171A (en) Detection of antibody against human immune failure virus by agglutination of antigen cover latex
DE69130396D1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
AU6727798A (en) Method for simultaneous detection of hiv antigens and hiv antibodies
DE3854553T2 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
TW222686B (de)
AU7444891A (en) New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method
ES8609724A1 (es) Un inmunoensayo para detectar el anticuerpo del antigeno su-perficial-a de la hepatitis b
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE3679926D1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
EP0402757A3 (de) Festphasenimmunoassay und Testbesteck zur Bestimmung von Antigenen und Antikörpern
DE69228720D1 (de) Liposome-Immunoassay zum Nachweis von Antigenen, Antikörpern und Haptenen
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
GR3023963T3 (en) Immunoelectrophoresis method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931119

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AKZO NOBEL N.V.

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980212

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOMERIEUX, INC.

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

REF Corresponds to:

Ref document number: 223050

Country of ref document: AT

Date of ref document: 20020915

Kind code of ref document: T

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69332236

Country of ref document: DE

Date of ref document: 20021002

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ARNOLD & SIEDSMA AG

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20020403843

Country of ref document: GR

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20021105

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2182825

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: INSTITUT PASTEUR

Effective date: 20030528

NLR1 Nl: opposition has been filed with the epo

Opponent name: INSTITUT PASTEUR

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20031031

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20031103

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20031110

Year of fee payment: 11

Ref country code: MC

Payment date: 20031110

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20031119

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20031121

Year of fee payment: 11

Ref country code: CH

Payment date: 20031121

Year of fee payment: 11

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20031127

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20031128

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20040115

Year of fee payment: 11

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

R26 Opposition filed (corrected)

Opponent name: INSTITUT PASTEUR

Effective date: 20030528

NLR1 Nl: opposition has been filed with the epo

Opponent name: INSTITUT PASTEUR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041119

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041119

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050519

BERE Be: lapsed

Owner name: *BIOMERIEUX INC.

Effective date: 20041130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050602

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Effective date: 20050519

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20050601

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PLBD Termination of opposition procedure: decision despatched

Free format text: ORIGINAL CODE: EPIDOSNOPC1

PLBP Opposition withdrawn

Free format text: ORIGINAL CODE: 0009264

PLBM Termination of opposition procedure: date of legal effect published

Free format text: ORIGINAL CODE: 0009276

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION PROCEDURE CLOSED

27C Opposition proceedings terminated

Effective date: 20061027

BERE Be: lapsed

Owner name: *BIOMERIEUX INC.

Effective date: 20041130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20121128

Year of fee payment: 20

Ref country code: FR

Payment date: 20121206

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20121126

Year of fee payment: 20

Ref country code: SE

Payment date: 20121126

Year of fee payment: 20

Ref country code: GB

Payment date: 20121126

Year of fee payment: 20

Ref country code: IT

Payment date: 20121126

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69332236

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69332236

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20131118

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20131120

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20131118

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20140306

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20131120